A carregar...
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
BACKGROUND: Bevacizumab has recently been approved by the US Food and Drug Administration for recurrent glioblastoma (GBM). However, patterns of relapse, prognosis, and outcome of further therapy after bevacizumab failure have not been studied systematically. METHODS: We identified patients at Memor...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Academy of Neurology
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2839807/ https://ncbi.nlm.nih.gov/pubmed/19822869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181bc0184 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|